Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Steinman L, Fox E, Hartung HP, Alvarez E, et al. Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis. N Engl J Med 2022;387:704-714.
PMID: 36001711


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016